Department of Neurology, Cedars-Sinai Medical Center, 127 South San Vicente Boulevard, A6600, Los Angeles, CA 90048, USA.
Department of Neurological Sciences, University of Vermont, Larner College of Medicine, University Health Center, Arnold 2, 1 South Prospect Street, Burlington, VT 05401, USA.
Neurol Clin. 2024 Feb;42(1):1-13. doi: 10.1016/j.ncl.2023.07.001.
Multiple sclerosis (MS) misdiagnosis in the form of an incorrect diagnosis of MS, as well as delayed diagnosis in patients who do have MS, both influence patient clinical outcomes. Contemporary studies have reported data on factors associated with these diagnostic challenges and their frequency. Expediting diagnosis in patients with MS and reducing MS misdiagnosis in patients who do not have MS may be aided by educational efforts surrounding early MS symptoms and proper application of MS diagnostic criteria. Emerging novel MS diagnostic biomarkers may aid early and accurate diagnosis of MS in the future.
多发性硬化症（MS）的误诊形式为不正确的 MS 诊断，以及确实患有 MS 的患者的延迟诊断，这两者均会影响患者的临床结局。当代研究已经报告了与这些诊断挑战及其频率相关的因素的数据。围绕 MS 的早期症状和 MS 诊断标准的正确应用进行教育，可能有助于加快 MS 患者的诊断并减少 MS 误诊。新兴的 MS 诊断生物标志物可能有助于未来 MS 的早期和准确诊断。
